Literature DB >> 24174128

Non-pharmacological modulation of the autonomic tone to treat heart failure.

Jagmeet P Singh1, Jagdesh Kandala, A John Camm.   

Abstract

The autonomic nervous system has a significant role in the pathophysiology and progression of heart failure. The absence of any recent breakthrough advances in the medical therapy of heart failure has led to the evolution of innovative non-pharmacological interventions that can favourably modulate the cardiac autonomic tone. Several new therapeutic modalities that may act at different levels of the autonomic nervous system are being investigated for their role in the treatment of heart failure. The current review examines the role of renal denervation, vagal nerve stimulators, carotid baroreceptors, and spinal cord stimulators in the treatment of heart failure.

Entities:  

Keywords:  Autonomic nervous system; Baroreflex sensitivity; Carotid baroreceptor stimulation; Heart rate variability; Parasympathetic nervous system; Renal denervation; Spinal cord stimulation; Sympathetic nervous system; Vagal nerve stimulator

Mesh:

Year:  2013        PMID: 24174128     DOI: 10.1093/eurheartj/eht436

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

Review 1.  Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.

Authors:  Roy Emanuel; Astha Chichra; Nirav Patel; Thierry H Le Jemtel; Abhishek Jaiswal
Journal:  Ann Transl Med       Date:  2018-08

Review 2.  Monitoring fetal maturation-objectives, techniques and indices of autonomic function.

Authors:  Dirk Hoyer; Jan Żebrowski; Dirk Cysarz; Hernâni Gonçalves; Adelina Pytlik; Célia Amorim-Costa; João Bernardes; Diogo Ayres-de-Campos; Otto W Witte; Ekkehard Schleußner; Lisa Stroux; Christopher Redman; Antoniya Georgieva; Stephen Payne; Gari Clifford; Maria G Signorini; Giovanni Magenes; Fernando Andreotti; Hagen Malberg; Sebastian Zaunseder; Igor Lakhno; Uwe Schneider
Journal:  Physiol Meas       Date:  2017-02-10       Impact factor: 2.833

Review 3.  Cardiac molecular imaging to track left ventricular remodeling in heart failure.

Authors:  Jamshid Shirani; Amitoj Singh; Sahil Agrawal; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2016-08-01       Impact factor: 5.952

4.  Renal Denervation to Treat Heart Failure.

Authors:  Thomas E Sharp; David J Lefer
Journal:  Annu Rev Physiol       Date:  2020-10-19       Impact factor: 19.318

5.  Intermittent low-level vagosympathetic nerve trunk stimulation inhibits ganglionated plexi activity to prevent atrial fibrillation.

Authors:  Yanmei Lu; Juan Sun; Ling Zhang; Qingquan Sun; Xianhui Zhou; Jinxin Li; Yu Zhang; Baopeng Tang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation.

Authors:  Janine Giese-Davis; Frank H Wilhelm; Rie Tamagawa; Oxana Palesh; Eric Neri; Craig Barr Taylor; Helena C Kraemer; David Spiegel
Journal:  Psychosom Med       Date:  2015-05       Impact factor: 4.312

7.  Impaired signaling intrinsic to sinoatrial node pacemaker cells affects heart rate variability during cardiac disease.

Authors:  Yael Yaniv; Alexey E Lyashkov; Edward G Lakatta
Journal:  J Clin Trials       Date:  2014-03

8.  Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade.

Authors:  Heitaro Watanabe; Yoshitaka Iwanaga; Yuki Miyaji; Hiromi Yamamoto; Shunichi Miyazaki
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

9.  Device-Based Approaches to Modulate the Autonomic Nervous System and Cardiac Electrophysiology.

Authors:  William J Hucker; Jagmeet P Singh; Kimberly Parks; Antonis A Armoundas
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-05-30

Review 10.  Muscarinic Stimulation Facilitates Sarcoplasmic Reticulum Ca Release by Modulating Ryanodine Receptor 2 Phosphorylation Through Protein Kinase G and Ca/Calmodulin-Dependent Protein Kinase II.

Authors:  Hsiang-Ting Ho; Andriy E Belevych; Bin Liu; Ingrid M Bonilla; Przemysław B Radwański; Igor V Kubasov; Héctor H Valdivia; Karsten Schober; Cynthia A Carnes; Sándor Györke
Journal:  Hypertension       Date:  2016-09-19       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.